Investing.com - Lifecore Biomedical (NASDAQ: LFCR) reported fourth quarter EPS of $-0.18, in line with the analyst estimate of $-0.18. Revenue for the quarter came in at $28M versus the consensus estimate of $28M.
Lifecore Biomedical's stock price closed at $4.40. It is down -28.10% in the last 3 months and down -50.23% in the last 12 months.
Lifecore Biomedical saw 0 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Lifecore Biomedical's stock price’s past reactions to earnings here.
According to InvestingPro, Lifecore Biomedical's Financial Health score is "weak performance".
Check out Lifecore Biomedical's recent earnings performance, and Lifecore Biomedical's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar